Arkolith/Insider Trading/LXRX/Form 4

Crum Brian T

SVP, General Counsel & Secr.LEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2026Grant(A)450K—$0450K
Feb 12, 2026Grant(A)300K—$0300K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML